ATHX - avg. in at 3 BUT HUGE NEWS !

Here is why... They are really the #1 player in stem cells. Do your DD, but dont wait too long. I actually came here and was still cheering them on at 4. I even bought that high... Avg. in at this price.

They have phase II trial results coming out within 2 weeks. VERY IMPORTANT ! They are partnered with pfizer on this study, A UC study. The big news is that yesterday the FDA said they see promise in Cell therapy and are studying to catch up with the companies. ATHX is one talking to congress soon about it.

Even bigger is that yesterday the WORLD Regen society laid out their plans for their meeting which is MAY 21st. This date is important because ATHX made reservations for Dr. Gil to peak, twice, Dr. Harrington once. ALSO the top dog in PFIZER regen business is also speaking, and a second speaker twoo from pfizer.

No way in hell do both of these companies speak at this one, or the one in 2 days which has one rep from each company unless they know the results. The results have to be completely tabulated and as they have said, they are doing it now. But you dont set up to have a rep from both companies do keynote type of speeches at this seminar.

It is huge news and shows efficacy.... Look for no less than 4 bucks which is 25% from here for you. if they and Pfizer can PR it properly it may reak 10. I am telling you this is the shit...

They are way ahead of everyone except Mesoblast because they already have it in manufacturing, has been for two years, they know it will work. That is one of the speeches, by Dr. Harrington on development - Commercialization of Multistem...

Plus, they just got back from Japan where they change regulations to advance cell therapy, prove a phase I or II is safe and shows efficacy, you can commercialize... That is also huge, and ATHX has all the patents to cover their product. Their Adult stem cells are head and shoulders above MSCs which is where most are studying...

I think they go really big. And they are a play you can count on to go up and down with time. They move very methodical. They have 2 more studies coming out this year on AMI (heart) and GVHD.. graft vs host diease. The latter already has shown to work thru a company that buys a product like multistem from ATHX. RTI surgical has proven it works...

Catalyst - times when news will come out !

1. 8 week results due out within two weeks.

2. 16 week results from same study that wont take 8 more weeks because we are at the 16 week time for the last patient.

3. Start of a study and partnership in Japan on stroke.

4. End of stroke phase II trial (before the end of the summer)

5. Start of the other two trials.

6. What will PFE n ATHX do with the resluts, phase III probably... and they said 6 months ago it will advance onto crohns diease.

7. I dont know.... But as you can see, there must be efficacy. You don't continue on with everything they have done without knowing you are the garbage.

8. PROBLEMS - They move, maybe a little to slow, to precise. They have said they always want the FDA input on everything on a study... It is almost as if they love doing these studies. Their burn rate is increasing and maybe, just maybe, they have too many studies out. Once you have efficacy, go make some money. Or increase your value, they dilute. Not the opposite as it seems to be (sometimes).

9. That leads us to the great oppurtuity in ATHX, it is always going to go up, but with downs and slower timelines. The shorts know thsi company and did a grewat job of pounding it down recently... That is something everyone can learn to play.

Even more news yesterday with them Partnering with Catapult. Catapult was created by the U.K. to advance cell therapies "that work" through their system. Although ATHX has not put out the UC results. It is clear they are moving forward.